Tuesday, July 25, 2006
SHIRE ANNOUNCES FILING OF SPD465 FOR THE TREATMENT OF ADULT ADHD
Shire is seeking FDA approval for SPD465, which contains the same active ingredient as Adderall XR. SPD465 will control AD/HD symptoms for up to 16 hours. Click on the link above for more details.
